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Objectives. This study aimed to explore the eﬀect of exendin-4 on t-BHP-induced apoptosis in pancreatic β cells and the
mechanism of action. Methods. Murine MIN6 pancreatic β cells were treated with exendin-4 in the presence or absence of tert-
butyl hydroperoxide (t-BHP). Cell survival was assessed by MTT staining. The percentage of apoptotic cells was determined
by ﬂuorescence microscopy analysis after Hoechst/PI staining and ﬂow cytometric assay after Annexin V-FITC/PI staining. The
activity of caspase-3 was determined using a caspase-3 activity kit. Expression of P-IRE1α, IRE1α, C-Jun N-terminal kinase (JNK),
P-JNK, C-JUN, and P-C-JUN was detected by western blotting. Results. Exendin-4 was found to inhibit t-BHP-induced apoptosis
in pancreatic β-cells by downregulating caspase-3 activity. Exendin-4 also inhibited the endoplasmic reticulum transmembrane
protein IRE1, the apoptosis-related signaling molecule JNK, and c-Jun activation. Conclusions. Our ﬁndings suggest that exendin-
4ultimatelyreducest-BHP-inducedβ-cellapoptosis.IRE1-JNK-c-Junsignalingisinvolvedintheexendin-4-mediatedmodulation
of β-cell apoptosis.
1.Introduction
Type 2 diabetes is caused by complex interactions between
insulin resistance in the peripheral tissues and impaired
insulin secretion by pancreatic β-cells. There is a general
consensus that the latter results from both impaired β-
cell function and decreased β-cell mass. The high activity
of molecules, such as reactive oxygen species (ROS) and
clusters of reactive nitrogen species (RNS), could cause
oxidative damage, leading to tissue injury. The classical
pathwayofapoptosisincludesthecelldeathreceptorpathway
(extrinsic pathway) and the mitochondrial death pathway
(intrinsic pathway). Recent studies have revealed that the
endoplasmic reticulum (ER) is an organelle that can sense
various stresses and transmit apoptotic signals [1, 2]. One
characteristic feature of β-cells is a highly developed ER,
which arises from the large amounts of insulin secretion [3].
Abnormal oxidation and impaired protein folding can lead
to endoplasmic reticulum stress (ERS).
Glucagon-like peptide 1 (GLP-1), which is secreted in a
glucose-dependentmanner,isinvolvedinglucose-stimulated
insulinsecretion,insulinbiosynthesis,inhibitionofglucagon
secretion and gastric emptying, and the inhibition of food
intake. GLP-1 also inhibits β-cell apoptosis and promotes
β-cell proliferation in animals and cultured cells in vitro.
The chronic administration of GLP-1 also promotes insulin
synthesis, β-cell proliferation, and β-cell neogenesis [4–6].
An important locus for the regulation of GLP-1 biological
activity is the N-terminal of the peptide via dipeptidyl
peptidase IV (DPP-4)-mediated cleavage at the position 2
alanine. The half-life of active GLP-1 in the circulation
is only approximately 2min, which limits its clinical
value. Exendin-4 is a GLP-1 receptor agonist that is not
cleaved by DPP-4. Therefore, it has a longer half-life than
GLP-1andwouldbemoresuitableasatherapeuticagent[7].
At present, the action of GLP-1 on the ERS signaling
pathway in pancreatic β cells has not been fully explained.2 International Journal of Endocrinology
Yusta et al. [8] demonstrated that GLP-1 receptor signaling
directly modulates the ER stress response, leading to the
promotionofβ-celladaptationandsurvival.Ferdaoussietal.
[9] found that exendin-4 inhibits apoptosis elicited by IL-1,
which highlights the importance of GLP-1 mimetics as new
potent inhibitors of cytokine-induced JNK signaling.
Tert-butyl hydroperoxide (t-BHP) is an organic lipid
hydroperoxide analog, which is commonly used as a pro-
oxidant to evaluate mechanisms involving oxidative stress in
cells and tissues [10].Inthisstudy,weinvestigatedwhethert-
BHP can lead to ERS. Furthermore, we investigated whether
exendin-4 could protect β cells from t-BHP-induced apop-
tosis. Moreover, we explored the antiapoptotic molecular
mechanisms of exendin-4, including an assessment of the
ERS and JNK signaling pathways, in t-BHP-treated β cells.
2.MaterialsandMethods
2.1.Reagents. Exendin-4,t-BHP,Dulbecco’smodiﬁedEagle’s
medium (DMEM), Hanks’ balanced salt solution (HBSS),
and fetal bovine serum (FBS) were obtained from Gibco
(Grand Island, NY, USA). Primary antibodies, including
rabbit polyclonal antibodies to sheep P-IRE1α and IRE-
1α, were purchased from Santa Cruz Biotechnology (Santa
Cruz,CA,USA).RabbitpolyclonalantibodiestosheepNH2-
terminal kinase (JNK), p-JNK, c-Jun, p-c-Jun, caspase-3
werepurchasedfromCellSignaling(Beverly,MA,USA).The
JNK inhibitor, SP600125, was purchased from Invitrogen
(Invitrogen, Carlsbad, CA). Hoechst 33342/PI, caspase-
3 activity assay kits, and the Annexin V-FITC apoptosis
kit were purchased from Sigma-Aldrich (St. Louis, MO,
USA). The western blot chemiluminescent detection system
(LumiGLO system) was purchased from KPL (Gaithersburg,
MD, USA). All reagents were of analytical or cell culture
grade purity.
2.2. Cell Culture. The pancreatic MIN6 β-cell line was a
gift from the Institute of Endocrinology of Ruijin Hospital,
which is aﬃliated with Shanghai 2nd Medical University
(Shanghai, China). MIN6 cells were maintained in DMEM
supplemented with 15% FBS, 100 units/mL penicillin, and
100μg/mLstreptomycinandwerekeptat37◦Cinhumidiﬁed
airwith5%CO2.Thec ellsw e r egr o wnupt o75%c o nﬂ ue nc e
and passaged every 3 days.
2.3. Hoechst 33342/PI Staining. Cells were double-stained
with Hoechst 33342 and propidium iodide (PI) to distin-
guish apoptotic cells from necrotic cells. Cells were treated
with t-BHP (25μM) with or without exendin-4 (100nM)
for the indicated time, washed with PBS (pH 7.4), and then
stained with Hoechst 33342 (10μg/mL) and PI (10μg/mL)
for 5min at room temperature. One hundred cells were
selected at three independent times and counted under a
ﬂuorescence microscope, and the rate of apoptosis was then
calculated.
2.4. Annexin V/PI Assay. Annexin V-FITC binding and PI
staining were performed according to the manufacturer’s
protocol and then analyzed by ﬂow cytometry (FACScan,
Becton Dickinson). Apoptotic cells were deﬁned as the
populationthatwerePInegative(indicatinganintactplasma
membrane) and Annexin V-FITC positive.
2.5. Caspase-3 Activity Assay. The caspase-3 assay was per-
formed according to the manufacturer’s protocol. Brieﬂy
treated cells were washed once with ice-cold PBS and assayed
for caspase-3 activity using a colorimetric assay. Cleavage of
Ac-DEVD-pNA substrate by caspase-3 releases pNA, which
was quantiﬁed spectrophotometrically at 405nm using an
ELISA reader. The change in optical density is directly
proportional to caspase-3 activity.
2.6. Western Blot Analysis. The treated cells were rinsed
with ice-cold PBS and then incubated with RIPA lysis
buﬀer containing 50mM Tris-HCl (pH 7.4), 150mM
NaCl, 1% Triton-X 100, 1mM EDTA, 1mM NaF, 1mM
Na3VO4, 0.1% SDS, 0.5% (w/v) sodium deoxycholate,
1mM phenylmethanesulfonylﬂuoride (PMSF), 10μg/mL
aprotinin, 1μg/mL leupeptin, and 1μg/mL pepstatin for
20min. The cell lysates were then centrifuged at 12,000×g
for 10min, and the protein concentrations were determined
using the Bradford method. Total cell protein (50μg)
was separated by 8% or 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to PVDF membranes. The membranes were incu-
bated with the following appropriate primary antibodies:
P-IRE1α (1:1,000), IRE-1α (1:1,000), JNK (1:1,000), p-
JNK (1:1000), c-Jun (1:1,000), p-c-Jun (1:1,000), caspase-
3 (1:1,000). Secondary horseradish peroxidase-conjugated
antibody detection was performed with enhanced chemilu-
minescence reagents. Quantiﬁcation of the band density was
performed by densitometric analysis.
2.7. Statistical Analysis. Data were analyzed by SigmaStat
3.5 software and shown by the mean ± standard deviation
(SD) of at least three independent experiments. Statistical
diﬀerences between values were determined by Student’s
t-test or ANOVA followed by Tukey’s post hoc test. The
signiﬁcance level was set at P<0.05.
3. Results
3.1. Exendin-4 Inhibits t-BHP-Induced β-Cell Apoptosis. The
treatment of β-cells with 25μmol/L t-BHP produced the
maximal apoptotic response after 1h as evidenced by results
of the Hoechst/PI and Annexin V-FITC/PI assays (data
not shown). β cells treated with 25μmol/L t-BHP for 1h
clearly exhibited staining that was indicative of apopto-
sis (bright blue particles) (Figure 1(A)(b)). Interestingly,
exendin-4 treatment markedly inhibited the apoptotic bright
blue particle formation in MIN6 cells (Figure 1(A)(d)).
An Annexin V-FITC/PI quantiﬁcation assay demonstrated
that t-BHP-induced MIN6 cell death was mediated by
apoptosis (Figure 1(B)(b)) and that exendin-4 protected
MIN6 cells from t-BHP-induced apoptosis (Figure 1(B)(d)).
The inhibitory eﬀect of exendin-4 was 77.6% (P<0.001),International Journal of Endocrinology 3
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Figure 1: Exendin-4 inhibits t-BHP-induced β-cell apoptosis. MIN6 cells were preincubated with exendin-4 (100nM) or with SP600125
(10nM)for18handthenexposedtot-BHP(25μM) for 1h. The rate of apoptosis was determined by Hoechst/PI staining (A) and ﬂow
cytometry (B). The cells containing bright blue particles (apoptosis-positive cells) were visualized under a light microscope (A). (a) Control;
(b) t-BHP alone; (c) exendin-4 (Ex-4) alone; (d) Ex-4 + t-BHP; (e) SP600125 + t-BHP; (f) SP600125; (g) quantiﬁcation of apoptotic cells.
Values are expressed as the mean ± SD (n = 3).
∗∗∗P < 0.001 compared with the control group; ###P < 0.001 versus t-BHP alone.
whereas JNK inhibitor produced a 72.5% (P<0.001)
reduction in the level of apoptosis induced by t-BHP
(Figure 1(B)(e)), which suggested that JNK signaling is
involved in this process.
3.2. Exendin-4 Inhibits t-BHP-Induced Caspase-3 Activity. As
shown in Figures 2(a) and 2(b),e x p o s u r eo fM I N 6c e l l st o
25μmol/L t-BHP for 1h resulted in approximate 2.3-fold
Figure 2(a) and 7.5-fold Figure 2(b) (P<0.001) increases
in activity of the prototypic apoptotic marker caspase-
3. Pretreatment of cells with exendin-4 reduced caspase-3
activity levels to 44.7% Figure 2(a) and 72.8% Figure 2(b)
lower than that observed in the group treated with t-BHP
alone (P<0.001). This was similar to the protective eﬀect
of the JNK inhibitor, SP600125. These results suggest that
exendin-4 can attenuate t-BHP-induced apoptotic death by4 International Journal of Endocrinology
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Figure 2:Exendin-4inhibitscaspase-3activity int-BHP-treatedMIN6cells.MIN6cells werepreincubated withexendin-4 (100nM)orwith
SP600125 (10nM) for 18h and then exposed to t-BHP (25μM) for 1h. Caspase-3 activity was determined using a caspase-3 activity assay
(a) and western blotting (b), as described in Section 2. The histogram shows the quantiﬁcation of the protein data. Levels of active caspase-3
protein were normalized to caspase-3 levels and expressed as the relative fold change compared to the control samples. Values are expressed
as the mean ± SD (n = 3).
∗∗∗P < 0.001versus control group; ###P < 0.001versus the t-BHP group.
inhibiting the activation of caspase-3 in β cells and that JNK
signaling is involved.
3.3. Exendin-4 Inhibits t-BHP-Induced Increase in IRE. IRE1
is one of the three ER transmembrane proteins. Western blot
analysis showed that t-BHP increases IRE1 phosphorylation
by 2.6-fold (P<0.001) relative to the control group
(Figure 3). Pretreatment of cells with exendin-4 reduced the
t-BHP-induced increase in IRE phosphorylation by 58.7%
(P<0.001) compared to the t-BHP alone group. This
was similar to the protective eﬀect of the JNK inhibitor,
SP600125. These results indicated that ERS is probably
requiredfortheapoptoticeventsmediatedbyt-BHPandthat
JNK signaling is involved.
3.4. Exendin-4 Inhibits t-BHP-Induced Apoptosis via the JNK
Signaling Pathway. It is well known that the accumulation
of proteins in the lumen of the ER initiates a stress response
knownastheunfoldedproteinresponse (UPR)/endoplasmic
reticulum overload response (EOR). One of the pathways
activated after ERS is the SAPK/JNK pathway. Further
experiments showed that t-BHP increases JNK phospho-
rylation by 1.9-fold (P<0.001) (Figure 4(a))a n dc - J u n
phosphorylation by 1.7-fold (P<0.001) (Figure 4(b)).
Pretreatment of cells with exendin-4 reduced the t-BHP-
induced increase in JNK phosphorylation by 50.4% (P<
0.001)(Figure 4(a))andreducedthet-BHP-inducedincrease
in c-Jun by 84.9% (P<0.001) (Figure 4(b)). These results
suggest that exendin-4 attenuates t-BHP-induced apoptotic
death by modulating JNK-c-JUN signaling in β cells.
4. Discussion
In the present study, we investigated the eﬀects of exendin-
4 on t-BHP-induced apoptosis. We demonstrated that
exendin-4 protects pancreatic β cells from t-BHP-induced
apoptotic death via IRE1-JNK-caspase-3 signaling, which
suggests the probable involvement of ER stress in apoptosis.
Type 2 diabetes is associated with a gradual loss of
insulin secretion and a progressive reduction in β-cell mass.
Insulin resistance produces a sustained increase in demand
for insulin, and, over time, the β cells are unable to sustain
the augmented levels of insulin biosynthesis and secretion.
Pancreatic β cells are extremely sensitive to ERS. The ER
has several important functions, including posttranslational
modiﬁcation, folding, and assembly of newly synthesized
secretory proteins, and it also acts as a cellular calcium store.
ERS is conducive to the maintenance of the normal function
of cells and their survival; however, prolonged ERS can
induce cell apoptosis. Therefore, β-cell apoptosis induced
by chronic ERS is important in type 2 diabetes [11, 12].
In our previous studies, we demonstrated that MIN6 cell
viability, when treated with t-BHP, was reduced in a dose-
dependent manner. We also found that continuous exposure
to t-BHP induced oxidative damage in MIN6 cells [13].
The present study suggests that t-BHP treatment leads toInternational Journal of Endocrinology 5
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Figure 3: Exendin-4 inhibits t-BHP-induced increase in IRE1.
MIN6 cells were preincubated with exendin-4 (100nM) or with
SP600125 (10nM) for 18h and then exposed to t-BHP (25μM)
for 1h. Representative western blot images revealed the expression
levels of phospho-IRE and total IRE. The histogram shows the
quantiﬁcation of the protein data. Levels of phosphorylated protein
were normalized to the levels of total protein and expressed as
the relative fold change compared to the control samples. Values
correspond to the mean ± SD (n = 3).
∗∗∗P < 0.001 compared
with the control group; ###P < 0.001 versus t-BHP alone.
the activation of death eﬀector caspases, such as caspase-3,
resulting in nuclear fragmentation and apoptosis (Figures 1
and 2). Further, t-BHP might trigger apoptosis in β cells via
ERS signaling pathways (Figure 3).
IRE1 is one of the three ER transmembrane proteins.
A small fragment of the X-box binding protein 1 (XBP1)
mRNA is spliced out by the active form of IRE1 to
produce the active form of XBP1. This is supported by the
observation that the stress eﬀect caused by IRE is mediated
no later than the role of PEK-related endoplasmic reticulum
eukaryotic initiation factor 2α kinase (PERK) and activating
transcription factor 6 (ATF6) [14]. We believe that IRE is
the ﬁnal activated molecule in the stress response. However,
in response to ERS, IRE1α has been found to recruit the
adaptor protein, TNF receptor-associated factor 2 (TRAF2),
to the ER membrane. The IRE1α/TRAF2 complex then
recruits apoptosis signal regulating kinase 1 (ASK1), causing
activation of ASK1 and the downstream mitogen-activated
protein kinase family (MAPKs) cascades, which leads to cell
death [15].
JNK kinases (JNKs) have been extensively character-
ized. JNK activation occurs through phosphorylation of its
amino acid residues. Once activated, JNK is translocated
from the cytoplasm to the nucleus, which in turn induces
phosphorylation of its target transcription factor c-Jun [16].
The ER stress-mediated apoptosis pathway ﬁnally activates
the mitochondrial death pathway, leading to caspase-3
activation.Therefore,themitochondrialdeathpathwayplays
a role in synthesis and ampliﬁcation in this pathway [17].
In the present study, we observed that the JNK inhibitor,
SP600125, can inhibit the activity of caspase-3 (Figure 2);
t-BHP increased JNK phosphorylation by 1.9-fold (P<
0.001) (Figure 4(a)) and c-Jun phosphorylation by 1.7-
fold (P<0.001) (Figure 4(b)), suggesting that the JNK
signaling pathway is involved in the oxidative damage-
induced apoptosis pathway.
Exendin-4 can inhibit islet β-cell apoptosis induced by
oxidative damage [18]. Pandey and Rizvi [10] found that
when INS-1 cells were incubated with exendin-4 in the
presence or absence of IL-1, GLP-1 functioned as a potential
inhibitor of the JNK signaling pathway to protect cells
through the activation of drug induced apoptosis. There-
fore, GLP-1 receptor agonists have potentially important
applications in the treatment of diabetes. In our present
study,wealsofoundthatexendin-4inhibitedt-BHP-induced
β-cell apoptosis by 77.6% (P<0.001) (Figure 1(B)(d)).
Pretreatment of cells with exendin-4 reduced the t-BHP-
induced increase in JNK phosphorylation by 50.4% (P<
0.001)(Figure 4(a))andreducedthet-BHP-inducedincrease
in c-JUN by 84.9% (P<0.001) (Figure 4(b)). These eﬀects
were similar to those observed following pretreatment with
the JNK inhibitor, SP600125, suggesting that exendin-4
attenuates t-BHP-induced apoptotic death by modulating
JNK-c-JUN signaling in β cells.
High levels of ERS lead to the apoptosis of pancreatic β
cells [19]. The GLP-1 receptor agonist, exendin-4, protects
islet β cells by reducing the level of ERS [20]. Exendin-4
protects β cells against free fatty acids via the induction of
the ER chaperone BiP and the antiapoptotic protein JunB,
which mediate β-cell survival under lipotoxic conditions
[21]. We show that a certain degree of oxidative injury
produces obvious ERS and that the intracytoplasmic domain
of the ER transmembrane protein, IRE1α, undergoes self-
dimerization and phosphorylation-induced activation. IRE1
activationmaypromoteapoptosis,andexendin-4caninhibit
the activation of IRE1α to reduce the ERS response, thereby
protecting pancreatic β cells.
In recent years, the protective mechanisms of GLP-1 have
been elucidated. Cornu et al. [22] showed that regulation
of β-cell numbers and functions by GLP-1 depends on
the cAMP/protein kinase A-mediated induction of IGF-1R
expression and the increased activity of an IGF-2/IGF-1R
autocrine loop. Klinger et al. [23] demonstrated that the
cAMP/protein kinase A/CREB and MAPK/ERK1/2 pathways
can additively control β-cell proliferation, whereas Aikin
et al. [24] demonstrated that PI3K/AKT suppresses the
JNK pathway in islets and that this crosstalk represents an
important antiapoptotic consequence of PI3K/AKT activa-
tion. Widenmaier et al. [25] found that GLP-1 suppresses
p38 MAPK and JNK via Akt-mediated changes in the
phosphorylation state of the apoptosis signal-regulating
kinase 1 in INS-1 cells and human islets, which results in
the inhibition of its activity. Thus, a variety of interactions
appear to be involved in the GLP-1 protection of pancreatic
β cells against ER stress, such as CHOP, BiP, GRP78, XBP-1,6 International Journal of Endocrinology
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Figure 4: Exendin-4 inhibits t-BHP-induced aptosis via JNK signaling pathway. MIN6 cells were preincubated with exendin-4 (100nM)
or with SP600125 (10nM) for 18h and then exposed to t-BHP (25μM) for 1h. Representative western blot images revealed the expression
levelsofphospho-JNKandtotalJNKprotein(a);phospho-c-JUNandtotalc-JUN(b).Thehistogramshowsthequantiﬁcationoftheprotein
data. Levels of phosphorylated protein were normalized to the levels of total protein and expressed as the relative fold change compared to
the control samples. Values correspond to the mean ± SD (n = 3).
∗∗∗P < 0.001 compared with the control group; ###P < 0.001 versus
t-BHP alone.
ASK1, p-elf2α and AP1, amongst others, which remain to be
investigated.
5. Conclusions
The present study has demonstrated that exendin-4 has a
protective eﬀect against t-BHP-mediated β-cell apoptosis
through the inhibition of ER stress. We have shown that
IRE1-JNK-c-Jun-caspase-3 pathways are involved. However,
this study has only focused on one aspect of the ER stress
response. Future studies will aim to identify additional
downstream events that are regulated during persistent ER
stress.
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